Funding for this research was provided by:
Horizon 2020 Framework Programme (779257)
Damp Foundation (unknown)
Received: 1 March 2020
Accepted: 5 August 2020
First Online: 12 August 2020
Change Date: 22 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/S13023-021-01777-6
Ethics approval and consent to participate
: Not applicable as no patient or population data collected in the current paper.
: Not applicable as no patient or population data collected in the current paper
: Prof Riess receives financial support from Illumina for a diagnostic “Genome First” approach, Prof Lohmann received funds from the Damp Foundation, Prof Graessner has a consultancy contract with Roche and Prof Synofzik has received consultancy honoraria by Actelion Pharmaceuticals and speaker’s honoraria by the Movement Disorders Society, unrelated to this work.The remaining authors declare that they have no competing interests.